Back to All Events Advances in motion highlights our identification of stathmin-2 as a novel therapeutic target in TDP43-mediated ALS/FTD Thursday, January 17, 2019 7:00 PM 8:00 PM Google Calendar ICS https://advances.massgeneral.org/neuro/journal.aspx?id=1188
Advances in motion highlights our identification of stathmin-2 as a novel therapeutic target in TDP43-mediated ALS/FTD Thursday, January 17, 2019 7:00 PM 8:00 PM Google Calendar ICS https://advances.massgeneral.org/neuro/journal.aspx?id=1188